Determination of minimum hemagglutinin units in an inactivated Newcastle disease virus vaccine for clinical protection of chickens from exotic Newcastle disease virus challenge

Avian Diseases

Volumn 52, Issue 2, 2008, Pages 260-268

  Liljebjelke, K A ^a   King, D J ^a   Kapczynski, D R ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Chickens; Exotic Newcastle disease virus; Inactivated vaccines; Vaccine potency

Indexed keywords

INACTIVATED VACCINE; VIRUS HEMAGGLUTININ; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIRD DISEASE; CHICK EMBRYO; CHICKEN; DOSE RESPONSE; HEMAGGLUTINATION INHIBITION TEST; IMMUNOLOGY; ISOLATION AND PURIFICATION; NEWCASTLE DISEASE PARAMYXOVIRUS; VIROLOGY;

ANIMALS; CHICK EMBRYO; CHICKENS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININS, VIRAL; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; VACCINES, INACTIVATED; VIRAL VACCINES;

ANIMALIA; AVES; EXOTIC NEWCASTLE DISEASE VIRUS; GALLUS GALLUS; NEWCASTLE DISEASE VIRUS;

EID: 45849108708     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/8154-101907-Reg.1     Document Type: Article

References (25)

1. A.P.H.I.S. vaccination - a two-edged sword. Eradication of exotic Newcastle disease in Southern California 1971-1974. U.S. Department of Agriculture, Washington, DC. 1978.
2. A.P.H.I.S. Veterinary Services memorandum no. 800.90. U.S. Department of Agriculture, Washington, DC. 1998.
3. A.P.H.I.S. Code of Federal Regulations Title 9 volume 1 - animals and animal products. Part 113.205 - Newcastle disease virus. U.S. Department of Agriculture, Washington, DC. 2007.
4. A.P.H.I.S. Code of Federal Regulations Title 9 volume 1 - animals and animal products. Part 121.3 - VS select agents and toxins. U.S. Department of Agriculture, Washington, DC. 2007.
5. A.P.H.I.S. Code of Federal Regulations Title 9 volume 1 - animals and animal products. Part 121.10 Restricting access to select agents and toxins: security risk assessments. U.S. Department of Agriculture, Washington, DC. 2007.
6. Alexander, D. J. Newcastle disease and other Paramyxoviridae infections. Iowa State University Press, Ames, IA. 1997.
7. Alexander, D. J. Isolation and identification of avian pathogens. In: Newcastle disease and other paramyxoviruses. D. E. Swayne, J. R. Glisson, M. J. Jackwood, J. E. Pearson, and W. M. Reed, eds. American Association of Avian Pathologists, Kennett Square, Pennsylvania. 1998.
8. Barbeito, M. S., G. Abraham, M. Best, P. Cairns, P. Langevin, W. G. Sterritt, D. Barr, W. Meulapas, J. M. Sanchez-Vizcaino, M. Saraza, et al. Recommended biocontainment features for research and diagnostic facilities where animal pathogens are used. Rev. Sci. Tech. 14:8743-8787. 1995.
9. Claasen, I., R. Maas, A. Daas, and C. Milne. Feasibility study to evaluate the correlation between results of a candidate in vitro assay and established in vivo assays for potency determination of Newcastle disease vaccines. Pharmeuropa Biol. 1:53-65. 2003.
10. Claasen, I., R. Maas, H. Oei, A. Daas, and C. Milne. Validation study to evaluate the reproducibility of a candidate in vitro potency assay of Newcastle disease vaccines and to establish the suitability of a candidate biological reference preparation. Pharmeuropa Biol. 1:1-15. 2004.
11. de Wit, J. J., H. W. van de Sande, G. H. Counotte, and G. J. Wellenberg. Analysis of the results of different test systems in the 2005 global proficiency testing schemes for infectious bursal disease virus and Newcastle disease virus antibody detection in chicken serum. Avian Pathol. 36:177-183. 2007.
12. Festing, M. F., V. Baumans, R. D. Combes, M. Halder, C. F. Hendriksen, B. Howard, D. P. Lovell, G. J. Moore, P. Overend, and M. S. Wilson. Reducing the use of laboratory animals in biomedical research: problems and possible solutions. ATLA 26:283-301. 1998.
13. Goddard, R. D., R. A. Nicholas, and P. R. Luff. Serology-based potency test for inactivated Newcastle disease vaccines. Vaccine 6:530-532. 1998.
14. Goodman, S. A. USDA: progress toward in vitro tests and other trends. Devel. Biol. Stand. 86:41-47. 1996.
15. Halder, M. Three Rs potential in the development and quality control of immunobiologicals. ALTEX 18:13-47. 2001.
16. Kapczynski, D. R., and D. J. King. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak. Vaccine 23:3424-3433. 2005.
17. King, D. J. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge. Avian Dis. 43:745-755. 1999.
18. Maas, R. A., M. Komen, M. Van Diepen, H. L. Oei, and J. J. Claassen. Correlation of haemagglutinin-neuraminidase and fusion protein content with protective antibody response after immunization with inactivated Newcastle disease vaccines. Vaccine 21:3137-3142. 2003.
19. Nolen, R. S. Emergency declared: exotic Newcastle disease found in commercial poultry farms. J. Am. Vet. Med. Assoc. 222:411-417. 2003.
20. Office International des Epizooties. Terrestrial animal health code. Office International des Epizooties, Paris. 2003.
21. Reynolds, D. L., and A. D. Maraqa. Protective immunity against Newcastle disease: the role of antibodies specific to Newcastle disease virus polypeptides. Avian Dis. 44:138-144. 2000.
22. Seal, B. S., D. J. King, and H. S. Sellers. The avian response to Newcastle disease virus. Devel. Comp. Immunol. 24:257-268. 2000.
23. Stone, H. D. Influence of formulation on the efficacy of experimental oil-emulsion Newcastle disease vaccines. Avian Dis. 27:688-697. 1983.
24. Stone, H. D. Determination of hemagglutinin activity recovered from oil-emulsion Newcastle vaccines as a prediction of efficacy. Avian Dis. 29:721-728. 1985.
25. Stone, H. D. Newcastle disease oil emulsion vaccines prepared with animal, vegetable, and synthetic oils. Avian Dis. 41:591-597. 1997.